Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan;13(1):101-21.
doi: 10.2174/1570159X13666141210222725.

Anabolic-androgenic Steroid Use and Psychopathology in Athletes. A Systematic Review

Free PMC article

Anabolic-androgenic Steroid Use and Psychopathology in Athletes. A Systematic Review

Daria Piacentino et al. Curr Neuropharmacol. .
Free PMC article


The use of anabolic-androgenic steroids (AASs) by professional and recreational athletes is increasing worldwide. The underlying motivations are mainly performance enhancement and body image improvement. AAS abuse and dependence, which are specifically classified and coded by the DSM-5, are not uncommon. AAS-using athletes are frequently present with psychiatric symptoms and disorders, mainly somatoform and eating, but also mood, and schizophrenia-related disorders. Some psychiatric disorders are typical of athletes, like muscle dysmorphia. This raises the issue of whether AAS use causes these disorders in athletes, by determining neuroadaptive changes in the reward neural circuit or by exacerbating stress vulnerability, or rather these are athletes with premorbid abnormal personalities or a history of psychiatric disorders who are attracted to AAS use, prompted by the desire to improve their appearance and control their weights. This may predispose to eating disorders, but AASs also show mood destabilizing effects, with longterm use inducing depression and short-term hypomania; withdrawal/discontinuation may be accompanied by depression. The effects of AASs on anxiety behavior are unclear and studies are inconsistent. AASs are also linked to psychotic behavior. The psychological characteristics that could prompt athletes to use AASs have not been elucidated.

Keywords: Anabolic-androgenic steroids; doping; mood disorders; psychopathology; psychosis.


Fig. (1)
Fig. (1)
PRISMA flowchart of systematic review inclusion and exclusion.

Similar articles

See all similar articles

Cited by 23 articles

See all "Cited by" articles


    1. Lombardo J.A. Anabolic-androgenic steroids. NIDA Res. Monogr. 1990;102:60–73. - PubMed
    1. Giorgi A., Weatherby R.P., Murphy P.W. Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study. J. Sci. Med. Sport. 1999;2(4):341–355. doi: 10.1016/S1440-2440(99)80007-3. - DOI - PubMed
    1. Schroeder E.T., Vallejo A.F., Zheng L., Stewart Y., Flores C., Nakao S., Martinez C., Sattler F.R. Six-week improvements in muscle mass and strength during androgen therapy in older men. J. Gerontol. A Biol. Sci. Med. Sci. 2005;60(12):1586–1592. doi: 10.1093/gerona/60.12.1586. - DOI - PubMed
    1. Bahrke M.S., Wright J.E., Strauss R.H., Catlin D.H. Psychological moods and subjectively perceived behavioral and somatic changes accompanying anabolic-androgenic steroid use. Am. J. Sports Med. 1992;20(6):717–724. doi: 10.1177/036354659202000613. - DOI - PubMed
    1. Imanipour V., Sadeghi M., Mahdi F. Effects of anabolic-androgenic steroids drugs on increase of muscle injuries in bodybuilders who use these drugs. J. Sci. Med. Sport. 2004;7:7–8. doi: 10.1016/S1440-2440(04)80070-7. - DOI

MeSH terms